Overview
Pan-chyr Yang practices in Taiwan. Yang is rated as an Advanced expert by MediFind in the treatment of Lung Metastases. Their top areas of expertise are Lung Adenocarcinoma, EGFR Positive Lung Cancer, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).
Their clinical research consists of co-authoring 276 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 4 articles in the study of Lung Metastases.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- EGFR Positive Lung CancerYang isDistinguished. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaYang isDistinguished. Learn about Lung Adenocarcinoma.
- Lung CancerYang isDistinguished. Learn about Lung Cancer.
- Advanced
- Collapsed LungYang isAdvanced. Learn about Collapsed Lung.
- Lung MetastasesYang isAdvanced. Learn about Lung Metastases.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Avian InfluenzaYang isExperienced. Learn about Avian Influenza.
- Chronic Obstructive Pulmonary Disease (COPD)
- Lung NodulesYang isExperienced. Learn about Lung Nodules.
- MosaicismYang isExperienced. Learn about Mosaicism.
- NecrosisYang isExperienced. Learn about Necrosis.
- Pleural EffusionYang isExperienced. Learn about Pleural Effusion.